Use of Sedative Medications in the Intensive Care Unit

ABSTRACT

Current choices for sustained sedation in the critically ill include the benzodiazepines, the opiates, and propofol. Each of these groups of medications has their particular benefits: benzodiazepines provide the greatest amnesia, opiates are the only agents to provide analgesia, and propofol is the most easily titratable and the least likely to excessively accrue. The literature seems to favor propofol over the benzodiazepines as the most cost-effective solution to sustained sedation. A newly approved agent, dexmedetomidine, holds promise as a continuous infusion that can provide both anxiolysis and analgesia, but without the ventilatory depression seen in the other classes of sedatives. Further research is needed to determine the role of dexmedetomidine in the ICU. The emerging standard of care for sustained sedation is the use of standardized protocols, formulated with the help of clinical practice guidelines, and titrated with the guidance of sedation monitoring.

KEYWORD

Dexmedetomidine - benzodiazepines - propofol

REFERENCES

• 1 Shapiro B A, Warren J, Egol A B. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary.  Crit Care Med . 1995;  23 1596-1600
• 2 Schelling G, Stoll C, Haller M. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome.  Crit Care Med . 1998;  26 651-659
• 3 Krachman S L, D'Alonzo G E, Criner G J. Sleep in the intensive care unit.  Chest . 1995;  107 1713-1720
• 4 Meyer T J, Eveloff S E, Bauer M S, Schwartz W A, Hill N S, Millman R P. Adverse environmental conditions in the respiratory and medical ICU settings.  Chest . 1994;  105 1211-1216
• 5 Schein R MH, Hazday N, Pena M, Ruben B H, Sprung C L. Clinical antecedents to in-hospital cardiopulmonary arrest.  Chest . 1990;  98 1388-1392
• 6 Franklin C, Mathew J. Developing strategies to prevent inhospital cardiac arrest: analyzing responses of physicians and nurses in the hours before the event.  Crit Care Med . 1994;  22 244-247
• 7 Johnson K L, Cheung R B, Johnson S B, Roberts M, Niblett J, Manson D. Therapeutic paralysis of critically ill trauma patients: perceptions of patients and their family members.  Am J Crit Care . 1999;  8 490-498
• 8 Bailie G R, Cockshott I D, Douglas E J, Bowles B J. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients.  Br J Anaesth . 1992;  68 486-491
• 9 Langley M S, Heel R C. Propofol: a review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anesthetic.  Drugs . 1988;  35 334-372
• 10 MacKenzie S J, Kapadia F, Grant I S. Propofol infusion for control of status epilepticus.  Anaesthesia . 1990;  45 1043-1045
• 11 Brown L A, Levin G M. Role of propofol in refractory status epilepticus.  Ann Pharmacother . 1998;  32 1053-1059
• 12 Kelly D F, Goodale D B, Williams J. Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial.  J Neurosurg. . 1999;  90 1042-1052
• 13 Wagner B KJ, O'Hara D A, Hammond J S. Drugs for amnesia in the ICU.  Am J Crit Care . 1997;  6 192-201
• 14 McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series.Crit Care Med.  . 2000;  28(6) 1781-1784
• 15 Coomes T R, Smith S W. Successful use of propofol in refractory delirium tremens.  Ann Emerg Med. . 1997;  30(6) 825-828
• 16 Kanto J, Gepts E. Pharmacokinetic implications for the clinical use of propofol.  Clin Pharmacokinet . 1989;  17 308-326
• 17 Kowalski S D, Rayfield C A. A post hoc descriptive study of patients receiving propofol.  Am J Crit Care . 1999;  8 507-513
• 18 Foex P, Diedericks J, Sear J W. Cardiovascular effects of propofol.  J Drug Dev . 1991;  4(suppl 3) 3-9
• 19 Carrasco G, Molina R, Costa J. Propofol versus midazolam in short-, medium-, and long-term sedation of critically ill patients.  Chest . 1993;  103 557-564
• 20 Kumar A N, Achwartz D E, Lim K G. Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge.  Chest . 1999;  115 1198-1199
• 21 Bennett S N, McNeil M M, Bland L A. Postoperative infections traced to contamination of an intravenous anesthetic, propofol.  N Engl J Med . 1995;  333 147-154
• 22 Webb S A, Roberts B, Breheny F X, Golledge C L, Cameron P D, van Heerden P V. Contamination of propofol infusions in the intensive care unit: incidence and clinical significance.  Anaesth Intensive Care . 1998;  26 162-164
• 23 Valente J F, Anderson G L, Branson R D, Johnson D J, Davis K, Porembka D T. Disadvantages of prolonged propofol sedation in the critical care unit.  Crit Care Med . 1994;  22 710-712
• 24 Au J, Walker W S, Scott D HT. Withdrawal syndrome after propofol infusion.  Anaesthesia . 1990;  45 741-742
• 25 Bodenham A, Culank L S, Park G R. Propofol infusion and green urine.  Lancet . 1987;  2 740
• 26 Greenblatt D J. Sedation: intravenous benzodiazepines in critical care medicine. In:Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient.  3rd ed. Baltimore: Williams & Wilkins 1994: 321-326
• 27 Gilliland H EM, Prasad B K, Mirakhur R K, Fee J PH. An investigation of the potential morphine sparing effect of midazolam.  Anaesthesia . 1996;  51 808-811
• 28 Ostermann M E, Keenan S P, Seiferling R A, Sibbald W J. Sedation in the intensive care unit: a systematic review.  JAMA . 2000;  283 1451-1459
• 29 Kress J P, Pohlman A S, O'Connor M F, Hall J B. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.  New Engl J Med . 2000;  342 1471-1477
• 30 Kollef M H, Levy N T, Ahrens T S, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation.  Chest . 1998;  114 541-548
• 31 Hojer J, Baehrendtz S, Magnusson A, Gustafsson L L. A placebo controlled trial of flumazenil given by continuous infusion in severe benzodiazepine overdosage.  Acta Anaesthesiol Scand . 1991;  35 584-590
• 32 Shelly M P, Sultan M A, Bodenham A, Park G R. Midazolam infusions in critically ill patients.  Eur J Anaesthesiol . 1991;  8 21-27
• 33 Cammarano W B, Pittet J-F, Weitz S, Schlobohm R M, Marks J D. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients.  Crit Care Med . 1998;  26 676-684
• 34 Finley P R, Nolan P E. Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam.  Annals of Pharmacotherapy . 1989;  23 151-152
• 35 Grossman M, Abiose A, Tangphao O. Morphine-induced venodilation in humans.  Clin Pharmacol Ther . 1996;  60 554-560
• 36 Flacke J W, Flacke W E, Bloor B C, Van Etten P A, Kripke B J. Histamine release by four narcotics: a double-blind study in humans.  Anesth Analg . 1987;  66 723-730
• 37 McArdle P Intravenous analgesia. Crit Care Clinics .  1999;  15 89-105
• 38 Balestrieri F, Fisher S. Analgesics. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient 3rd ed. Baltimore: Williams & Wilkins 1994: 640-650
• 39 Smith D C, Bergen J M, Smithline H, Kirschner R. A trial of etomidate for rapid sequence intubation in the emergency department.  J Emerg Med . 2000;  18 13-16
• 40 Migden D R, Reardon R F. Etomidate sedation for intubation.  Am J Emerg Med . 1998;  16 101-102
• 41 Van Hamme J M, Ghoneim N M, Amber J J. Pharmacokinetics of etomidate, a new intravenous anesthetic.  Anesthesiol . 1978;  49 274
• 42 Wagner R L, White P F. Etomidate inhibits adrenocortical function in surgical patients.  Anesthesiol . 1984;  60 647
• 43 Kress J P, O'Connor M F, Pohlman A S. Sedation of critically ill patients during mechanical ventilation.  Am J Resp Crit Care Med . 1996;  153 1012-1018
• 44 McCollam J S, O'Neil M G, Norcross E D, Byrne T K, Reeves S T. Continuous infusions of lorazepam, midazolam and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.  Crit Care Med . 1999;  27 2454-2458
• 45 Barrientos-Vega R, Sanchez-Soria M M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.  Crit Care Med . 1997;  25 33-40
• 46 Chamorro C, DeLatorre F J, Montero A. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial.  Crit Care Med . 1996;  24 932-939
• 47 Pohlman A S, Simpson K P, Hall J B. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study.  Crit Care Med . 1994;  22 1241-1247
• 48 Weinbroum A A, Halpern P, Rudick V, Sorkine P, Freedman M, Geller E. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison.  Intensive Care Med . 1997;  23 1258-1263
• 49 Sanchez-Izquierdo-Riera J A, Caballero-Cubedo R E, Perez-Vela J L, Ambros-Checa A, Cantalapiedra-Santiago J A, Alted-Lopez E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient.  Anesth Analg . 1998;  86 1219-1224
• 50 Swart E, Strack van Schijndel J M R, van Loenen C A, Thijs L G. Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost effective.  Crit Care Med . 1999;  27 1461-1465
• 51 Jacobi J, Bjerke H S, Chalfin D. Revised clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.  Crit Care Med 2001 (in press).
• 52 Brook A D, Ahrens T S, Schaiff R, Prentice D, Sherman G, Shannon W. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation.  Crit Care Med . 1999;  27 2609-2615
• 53 Eisenach J C, DeKock M, Klimscha W. Alpha-2-adrenergic agonists for regional anesthesia: a clinical review of clonidine (1984-1995).  Anesthesiology . 1996;  85 655-674
• 54 Kamibayashi T, Maze M. Clinical uses of α₂-adrenergic agonists.  Anesthesiology . 2000;  93 1345-1349
• 55 Franowicz J S, Arnsten A F. The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys.  Psychopharmacology . 1998;  136 8-14
• 56 Hall J E, Uhrich T D, Barney J A, Arain S R, Ebert T J. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions.  Anesth Analg . 2000;  90 699-705
• 57 Venn R M, Bradshaw C J, Spencer R. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit.  Anaesthesia . 1999;  54 1136-1142
• 58 Precedex (dexmedetomidine hydrochloride injection), package insert. Manufactured by Abbott Laboratories, North Chicago, IL, February 2000
• 59 Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha-2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.  Anesthesiol . 1998;  89 574-584
• 60 Maze M, Virtanen R, Daunt D, Banks S J, Stover E P, Feldman D. Effects of dexmedetomidine, a novel imidazole sedative-anethetic agent, on adrenal steroidogenesis: in vivo and in vitro studies.  Anesth Analg . 1991;  73 204-208
• 61 Bhana N, Goa K L, McClellan K J. Dexmedetomidine.  Drugs . 2000;  59 263-268
• 62 Bachand R, Scholz J, Pinaud M. The effects of dexmedetomidine in patients in the intensive care setting.  Intensive Care Medicine . 1999;  25(suppl 1) S160
• 63 Martin E, Lehot J J, Manikis P. Dexmedetomidine: a novel agent for patients in the intensive care setting.  Intensive Care Medicine . 1999;  25(suppl 1) S160
• 64 Nasraway S A, Jacobi J, Murray M J. Sedation, analgesia and neuromuscular blockade of the critically ill adult: revised clinical practice guidelines for 2001.  Crit Care Med 2001; in press.
• 65 Riker R R, Picard J T, Fraser G L. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients.  Crit Care Med . 1999;  27 1325-1329
• 66 Luce J. Reducing the use of mechanical ventilation.  N Engl J Med . 1996;  335 1916-1917
• 67 Mascia M F, Koch M, Medicis J J. Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation and neuromuscular blockade in critical care.  Crit Care Med . 2000;  28 2300-2306